0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Immunoglobulin G4-Related Lesions in Autoimmune Diseases: Unusual Presentations at Atypical Sites—A Tale of 2 Cases with Literature Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immunoglobulin G4-related disease (IgG4-RD) coexisting with clinically apparent autoimmune diseases, such as rheumatoid arthritis (RA) or antiphospholipid syndrome (APS), is a rarely documented combination in the scientific literature. In this case-based review, we present 2 intriguing cases with preexisting autoimmune diseases, namely, RA and primary APS, who exhibited coexistent IgG4-related lesions at unusual sites. The first case pertains to a patient with known RA who presented with an encasing mass in the esophagus leading to stricture, with histopathological diagnosis of IgG4-RD.The second patient, diagnosed with primary APS, experienced breathlessness, and imaging revealed a right atrial mass. Histopathological examination of the mass confirmed IgG4-RD. Notably, both patients demonstrated significant clinical improvement upon initiation of steroid therapy. Rheumatoid arthritis patients commonly exhibit elevated levels of IgG4 in their sera; however, RA with coexisting IgG4-RD is rarely reported in the literature. Similarly, APS with IgG4-related lesions is exceedingly rare. Although there are few case reports and series on esophageal and cardiac IgG4-RD, the occurrence of such unusual location of IgG4-related lesions in the context of known autoimmunity is presented here for the first time.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: not found
          • Article: not found

          IgG4-related disease.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Immunoglobulin G4: an odd antibody.

            Despite its well-known association with IgE-mediated allergy, IgG4 antibodies still have several poorly understood characteristics. IgG4 is a very dynamic antibody: the antibody is involved in a continuous process of half-molecules (i.e. a heavy and attached light-chain) exchange. This process, also referred to as 'Fab-arm exchange', results usually in asymmetric antibodies with two different antigen-combining sites. While these antibodies are hetero- bivalent, they will behave as monovalent antibodies in most situations. Another aspect of IgG4, still poorly understood, is its tendency to mimic IgG rheumatoid factor (RF) activity by interacting with IgG on a solid support. In contrast to conventional RF, which binds via its variable domains, the activity of IgG4 is located in its constant domains. This is potentially a source of false positives in IgG4 antibody assay results. Because regulation of IgG4 production is dependent on help by T-helper type 2 (Th2) cells, the IgG4 response is largely restricted to non-microbial antigens. This Th2-dependency associates the IgG4 and IgE responses. Another typical feature in the immune regulation of IgG4 is its tendency to appear only after prolonged immunization. In the context of IgE-mediated allergy, the appearance of IgG4 antibodies is usually associated with a decrease in symptoms. This is likely to be due, at least in part, to an allergen-blocking effect at the mast cell level and/or at the level of the antigen-presenting cell (preventing IgE-facilitated activation of T cells). In addition, the favourable association reflects the enhanced production of IL-10 and other anti-inflammatory cytokines, which drive the production of IgG4. While in general, IgG4 is being associated with non-activating characteristics, in some situations IgG4 antibodies have an association with pathology. Two striking examples are pemphigoid diseases and sclerosing diseases such as autoimmune pancreatitis. The mechanistic basis for the association of IgG4 with these diseases is still enigmatic. However, the association with sclerosing diseases may reflect an excessive production of anti-inflammatory cytokines triggering an overwhelming expansion of IgG4-producing plasma cells. The bottom line for allergy diagnosis: IgG4 by itself is unlikely to be a cause of allergic symptoms. In general, the presence of allergen-specific IgG4 indicates that anti-inflammatory, tolerance-inducing mechanisms have been activated. The existence of the IgG4 subclass, its up-regulation by anti-inflammatory factors and its own anti-inflammatory characteristics may help the immune system to dampen inappropriate inflammatory reactions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Complement is activated by IgG hexamers assembled at the cell surface.

              Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feature of natural immune defense, a number of disease processes, and immunotherapies. How antibodies activate the complement cascade, however, is poorly understood. We found that specific noncovalent interactions between Fc segments of immunoglobulin G (IgG) antibodies resulted in the formation of ordered antibody hexamers after antigen binding on cells. These hexamers recruited and activated C1, the first component of complement, thereby triggering the complement cascade. The interactions between neighboring Fc segments could be manipulated to block, reconstitute, and enhance complement activation and killing of target cells, using all four human IgG subclasses. We offer a general model for understanding antibody-mediated complement activation and the design of antibody therapeutics with enhanced efficacy.
                Bookmark

                Author and article information

                Journal
                Eur J Rheumatol
                Eur J Rheumatol
                European Journal of Rheumatology
                Mesut Onat
                2147-9720
                2148-4279
                October 2023
                01 October 2023
                : 10
                : 4
                : 169-175
                Affiliations
                Clinical Immunology and Rheumatology , Nizam’s Institute of Medical Sciences, Hyderabad, India
                Author notes
                Corresponding author:Keerthi Vardhan YerramE-mail: k.undefined5@ 123456gmail.com

                ORCID iDs of the authors: K.V.Y. 0000-0002-4536-7338; R.B. 0000-0002-3241-0229; A.B. 0000-0003-4319-0388; P.K.D. 0000-0002-6251-7828; L.R. 0000-0002-9789-9985.

                Cite this article as: Baisya R, Yerram KV, Baby A, Devarasetti PK, Rajasekhar L. IgG4-related lesions in autoimmune diseases: Unusual presentations at atypical sites—A tale of 2 cases with literature review. Eur J Rheumatol. 2023; 10(4): 169-175.

                Author information
                http://orcid.org/0000-0002-4536-7338
                http://orcid.org/0000-0002-3241-0229
                http://orcid.org/0000-0003-4319-0388
                http://orcid.org/0000-0002-6251-7828
                http://orcid.org/0000-0002-9789-9985
                Article
                ejr-10-4-169
                10.5152/eurjrheum.2023.23052
                10765183
                37873667
                7e0328ef-4294-42ed-9f50-8bc280b12c8d
                2023 authors

                Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 13 June 2023
                : 13 September 2023
                Categories
                Review Article

                igg4-rd,cardiac igg4-rd,esophageal igg4-rd,ra,primary aps
                igg4-rd, cardiac igg4-rd, esophageal igg4-rd, ra, primary aps

                Comments

                Comment on this article